The designer opened up about "using substances" in his HGTV special "My Lottery Dream Home: David’s Happy Ending" Marina Watts is a Digital Writer, Music at PEOPLE. She has been working at PEOPLE ...
The rejected application was based on data from the NORSE clinical trial program, including the pivotal NORSE TWO trial and the NORSE EIGHT study, which evaluated ONS-5010 versus ranibizumab. Outlook ...
TOKYO & MUNICH, December 18, 2025--(BUSINESS WIRE)--The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY ® (datopotamab deruxtecan) ...
LANGHORNE, Pa., December 22, 2025--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it ...
Israel’s Ministry of Health authorizes individual patients early access treatment with GS010/LUMEVOQ ®, a candidate gene therapy for the treatment of ND4-LHON. Bilateral injection expected to be ...
An inpatient mental health treatment center is one of the best ways to get through an acute (immediate) mental health crisis. Our inpatient mental health center is a safe place where you or a loved ...
MONTREAL, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback